NCT01628731View on ClinicalTrials.gov

Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

November 30, 2013

Conditions
Fluid Overload
Interventions
DRUG

furosemide

furosemide, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours

DRUG

ethacrynic acid

ethacrynic acid, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours

Trial Locations (1)

00165

Bambino Gesù Hospital, Rome

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT01628731 - Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease | Biotech Hunter | Biotech Hunter